2011
DOI: 10.1007/s00417-011-1810-x
|View full text |Cite
|
Sign up to set email alerts
|

Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid

Abstract: MMP-9, MMP-13 and TIMP-1 expression may serve as a prognostic marker for early tumor invasiveness. Moreover, up-regulation of TIMP-1 in tumor and/or surrounding stromal cells may indicate an increased risk for BCC recurrence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 33 publications
0
16
0
Order By: Relevance
“…Matrix metalloproteinase 13 is induced during metastasis of various cancers including squamous cell carcinomas of the head and neck and is associated with a poor clinical outcome. Thus, MMP13 may serve as a prognostic marker for tumor invasiveness …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Matrix metalloproteinase 13 is induced during metastasis of various cancers including squamous cell carcinomas of the head and neck and is associated with a poor clinical outcome. Thus, MMP13 may serve as a prognostic marker for tumor invasiveness …”
Section: Discussionmentioning
confidence: 99%
“…Thus, MMP13 may serve as a prognostic marker for tumor invasiveness. (30) This article focuses on the role of exosomes in cell-cell and cell-stroma interactions in facilitating the metastasis of NPC cells. As the molecular composition of exosomes closely reflects the specialized functions of the parental cells of origin, (13) we found MMP13 overexpressed in NPC exo (Fig.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…MMP-1 is the primary collagenolytic enzyme in BCC and expressed at various intensities in epithelial tumour cells and surrounding stromal cells, including fibroblasts, inflammatory cells and vascular endothelial cells [157,158]. The expression of MMP-1 is significantly enhanced at the invasive front of BCC, suggesting its role in the initial steps of tumour proliferation; even when potentially important variables such as age and individual variability are controlled for, tumour-specific effects on the expression of MMP-9 and MMP-1 also need be taken into consideration [159].…”
Section: Collagenasesmentioning
confidence: 99%
“…Experimental models, mostly based on MMP-9 knockout mice, have provided unequivocable evidences about the pivotal role played by the enzyme in tumour growth, invasiveness and angiogenesis [61]. MMP-9 prominently expressed at the invading edge of the BCC and was mostly secreted by inflammatory cells, such as macrophages, rather than by tumour cells [158,168]. Odds ratio for development of morpheaform and recurrent BCC was 5.8 for positive MMP-9 immunostaining in tumour stroma, suggesting MMP-9 expression in stromal cells is associated with morpheaform and recurrent BCC [161].…”
Section: Gelatinasesmentioning
confidence: 99%